跳至主要内容
临床试验/JPRN-UMIN000022333
JPRN-UMIN000022333已完成未知

The Blood concentration confirmation study on silymarin formulation of process materials. - The Blood concentration confirmation study on silymarin formulation of process materials.

FANCL Corporation0 个研究点目标入组 10 人开始时间: 2016年5月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1)Subjects who previous serious disease. 2)Subjects who are taking medicine or being treated by a doctor 3)Subjects who previous or present serious disease that affect the digestion or being treated by a doctor because of the digestive tract disease 4)Subjects who plan to receive treatment or medication by a doctor during the study 5)Subjects who has chrysanthemum allergy 6)Subjects who use specified healthy food, supplement containing silymarin within the last one month prior to the current study 7)Subjects who cannot be performed over time blood collection 8)Subjects who are judged as unsuitable for the study by the investigator for other reason

研究者

相似试验